Damora Therapeutics, Inc.

Direct answer

Damora Therapeutics, Inc. is publicly traded on NASDAQ under the ticker DMRA.

Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi,...

Can you invest in Damora Therapeutics, Inc.?

Yes. Damora Therapeutics, Inc. trades publicly on NASDAQ as DMRA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Damora Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.